JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER

Company

Indivior Pharmaceuticals, Inc.

Filed

February 27, 2025

Period of Report

February 27, 2025

Accession Number

0001654954-25-001997